
Matthew Porembka
Associate Professor · University of Texas Southwestern Medical Center
Credentials: · · · · ·
History
Research
A STING-activating nanovaccine for cancer immunotherapy
Nature Nanotechnology · 2017 · 669 citations
Journal of Clinical Oncology · 2017 · 324 citations
Cancer immunology · 2012 · First of 9 authors · 224 citations

66 papers

52 papers

50 papers · 5 as a fellow

47 papers

36 papers

25 papers · 25 as a resident

22 papers

18 papers · 15 as a resident
Clinical trials
- 2025–2028
PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)
Site PI · Recruiting · Phase 1
PanTher Therapeutics






